Literature DB >> 1320233

Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura.

D J O'Donoghue1, P Nusbaum, L H Noel, L Halbwachs-Mecarelli, P Lesavre.   

Abstract

The frequency, isotype, and specificity of antineutrophil cytoplasmic antibodies were investigated in a cross-sectional study of 100 patients with IgA nephropathy and 30 children with Henoch-Schönlein purpura. Two of the patients with IgA nephropathy had high titres of antineutrophil cytoplasmic antibodies which were of IgG isotype and confirmed as antimyeloperoxidase antibodies in solid-phase ELISA and inhibition experiments. Antineutrophil cytoplasmic antibodies were not detected in the children with Henoch-Schönlein purpura and none of the patients in either group had IgA antineutrophil cytoplasmic antibodies. A further 20 IgA nephropathy and 10 Henoch-Schönlein purpura patients were studied longitudinally in different clinical phases at 4-monthly intervals over a 2-year period. None of these patients had or developed antineutrophil cytoplasmic antibodies. We conclude that IgA antineutrophil cytoplasmic antibodies are not involved in the vasculitis of Henoch-Schönlein purpura or in the pathogenesis of glomerular injury in IgA nephropathy. The detection of IgG antimyeloperoxidase antibodies in a small minority of IgA nephropathy patients extends the spectrum of diseases associated with autoimmunity to this antigen but is of uncertain significance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320233

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

Review 1.  Antineutrophil cytoplasm antibodies and vasculitis.

Authors:  M C Nash; M J Dillon
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

2.  ANCA-positive IgA nephropathy without necrotising or crescentic glomerulonephritis: a clinical conundrum.

Authors:  Abhilash Koratala; Xu Zeng; Amir Kazory
Journal:  BMJ Case Rep       Date:  2017-11-23

3.  The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schönlein purpura.

Authors:  W L Robson; A K Leung; R C Woodman
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

Review 4.  Adult-onset Henoch-Schonlein purpura with positive c-ANCA (anti-proteinase 3): case report and review of literature.

Authors:  Eman Boulis; Vikas Majithia; Robert McMurray
Journal:  Rheumatol Int       Date:  2010-10-21       Impact factor: 2.631

5.  Coexistence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and IgA nephropathy.

Authors:  Yong Zhong; Xiangcheng Xiao; Qi Xiong; Wei Lin; Chanjuan Shen; Ting Meng; Rong Tang; Joshua D Ooi; Peter J Eggenhuizen; Jinbiao Chen; Wannian Nie; Xia Li; Qiaoling Zhou; Ping Xiao
Journal:  Immunol Res       Date:  2022-10-13       Impact factor: 4.505

6.  Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura.

Authors:  N Ronda; V L Esnault; L Layward; V Sepe; A Allen; J Feehally; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

7.  ANCA and IgA glomerulonephritis all in one: prognosis and complications.

Authors:  Pitchaphon Nissaisorakarn; Vivette D'Agati; Kisra Anis; Belinda Jim
Journal:  BMJ Case Rep       Date:  2017-10-09

Review 8.  IgA nephropathy with serum ANCA positivity: case series and literature review.

Authors:  Gabriel Ștefan; George Terinte-Balcan; Simona Stancu; Adrian Zugravu; Mihaela Gherghiceanu; Gabriel Mircescu
Journal:  Rheumatol Int       Date:  2021-05-17       Impact factor: 2.631

9.  Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study.

Authors:  Ya-Zi Yang; Su-Fang Shi; Yu-Qing Chen; Min Chen; Yi-He Yang; Xin-Fang Xie; Rong Zou; Ji-Cheng Lv; Li-Jun Liu; Hong Zhang
Journal:  Clin Kidney J       Date:  2015-08-30

10.  Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy.

Authors:  Adem Kucuk; Yalcin Solak; Abduzhappar Gaipov; Sinan Bagcaci; Hasan Esen; Suleyman Turk; Recep Tunc
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.